![Marvin Moser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marvin Moser
Directeur/Membre du Conseil chez The Trudeau Institute
Profil
Marvin Moser is a Trustee at The Trudeau Institute.
Previously, he was a Director at NXXI, Inc. from 1997 to 2008.
He was also a Trustee at Comprehensive NeuroScience, Inc. Dr. Moser received his undergraduate degree from Cornell University.
Postes actifs de Marvin Moser
Sociétés | Poste | Début |
---|---|---|
The Trudeau Institute | Directeur/Membre du Conseil | - |
Anciens postes connus de Marvin Moser
Sociétés | Poste | Fin |
---|---|---|
NXXI, Inc.
![]() NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Directeur/Membre du Conseil | 13/07/2008 |
Comprehensive NeuroScience, Inc.
![]() Comprehensive NeuroScience, Inc. Miscellaneous Commercial ServicesCommercial Services Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions. | Directeur/Membre du Conseil | - |
Formation de Marvin Moser
Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
NXXI, Inc.
![]() NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Health Technology |
Comprehensive NeuroScience, Inc.
![]() Comprehensive NeuroScience, Inc. Miscellaneous Commercial ServicesCommercial Services Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions. | Commercial Services |
The Trudeau Institute |